Cellens is a medical device company that provides clarity and focus on cancer detection.
Cellens has raised $6.5M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Cellens's investors include SOSV, IndieBio, Tufts University, Springboard Enterprises, LabCorp Venture Fund.
Cellens is headquartered in Medford, United States.
Cellens is a medical device company that provides clarity and focus on cancer detection.
Cellens is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cellens — Funding & Investors." VCBacked, December 23, 2025, https://www.vcbacked.co/company/cellens. Accessed July 19, 2026.
VCBacked. (2025). Cellens — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/cellens
{{cite web |title=Cellens — Funding & Investors |url=https://www.vcbacked.co/company/cellens |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated